European Respiratory Society Statement on Long COVID Follow-Up.

Katerina M. Antoniou (1) , Eirini Vasarmidi (2, 1) , Anne-Marie Russell (3) , Claire Andrejak (4, 5) , Bruno Crestani (6) , Marion Delcroix (7, 8) , Anh Tuan Dinh-Xuan (9) , Venerino Poletti (10, 11) , Nicola Sverzellati (12) , Michele Vitacca (13) , Martin Witzenrath (14) , Thomy Tonia (15) , Antonio Spanevello (16)

1 UOC - University of Crete [Heraklion]
2 PHERE (UMR_S_1152 / U1152) - Physiopathologie et Epidémiologie des Maladies Respiratoires
3 University of Exeter Medical School
4 AGIR - Agents infectieux, résistance et chimiothérapie - UR UPJV 4294
5 CHU Amiens-Picardie
6 AP-HP - Hôpital Bichat - Claude Bernard [Paris]
7 University Hospitals Leuven [Leuven]
8 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
9 Hôpital Cochin [AP-HP]
10 G.B. Morgagni-Pierantoni Hospital [Forlì, Italy]
11 Aarhus University Hospital
12 UNIPR - Università degli studi di Parma = University of Parma
13 Istituti Clinici Scientifici Maugeri IRCCS [Brescia]
14 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
15 UNIBE - Universität Bern / University of Bern
16 Uninsubria - Universitá degli Studi dell’Insubria = University of Insubria [Varese]

Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience symptom burden post-acute infection or post-hospitalisation. We aimed to identify optimal strategies for follow-up care that may positively impact the patient's quality of life (QoL). A European Respiratory Society (ERS) Task Force convened and prioritised eight clinical questions. A targeted search of the literature defined the timeline of "long COVID" as 1-6\hspace0.25emmonths post-infection and identified clinical evidence in the follow-up of patients. Studies meeting the inclusion criteria report an association of characteristics of acute infection with persistent symptoms, thromboembolic events in the follow-up period, and evaluations of pulmonary physiology and imaging. Importantly, this statement reviews QoL consequences, symptom burden, disability and home care follow-up. Overall, the evidence for follow-up care for patients with long COVID is limited.

Mots clés: *COVID-19/complications; Follow-Up Studies; Humans; Quality of Life; SARS-CoV-2

Domaines: Médecine humaine et pathologie

Katerina M. Antoniou, Eirini Vasarmidi, Anne-Marie Russell, Claire Andrejak, Bruno Crestani, et al.. European Respiratory Society Statement on Long COVID Follow-Up.. European Respiratory Journal, 2022, 60 (2), ⟨10.1183/13993003.02174-2021⟩. ⟨hal-03749904⟩